StemVax
is a biotechnology company that develops and commercializes stem cell-based immunotherapies for the treatment of brain tumor... Read moreStemVax
is a biotechnology company that develops and commercializes stem cell-based immunotherapies for the treatment of brain tumor... Read more
2014
2836 NAICS listing
News
Sep 10, 2020
FinanzNachrichten
StemVax: Innovest Global Inc.: Innovest Global Completes Sale of StemVax Therapeutics to NovAccess Global
Aug 11, 2020
Accesswire
Press Release: Stemvax : Innovest Global Enters into Agreement for the Sale of StemVax Therapeutics to XsunX, Inc.
Mar 03, 2020
LD Micro
Press Release: Stemvax : Innovest Global Acquires 100% of StemVax Therapeutics
Aug 06, 2018
StreetInsider
Press Release: Stemvax : Innovest Global: Signed Agreement with Cedars-Sinai Medical Center, Provides StemVax the Exclusive Worldwide Rights to Four Key Technologies
Jul 25, 2018
Benzinga
Stemvax: Innovest Global Announces Patent is Approved for StemVax Therapeutics
Jul 18, 2018
Contract Pharma
Stemvax: Innovest Global Launches Biotech Division
Mar 21, 2018
NewMediaWire
Press Release: Stemvax : Innovest Global, Inc. Announces LOI Acquiring 20% Stake In StemVax, LLC, Entering Into Cancer Vaccine Market - Spotlight Growth
Mar 19, 2018
GlobeNewswire
Press Release: Stemvax : Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company
Apr 10, 2017
benzinga.com
Stemvax: Quest Management Inc. Signs Letter of Intent to Acquire Immunotherapy Biotech Company Stemvax, Inc.
StemVax Competitors
1
2
3
4
5
6
7
8
9
10